Entity
Description
  • Value proposition

    Innovative neurosurgical technologies for epilepsy.

    NxNeuro is developing technologies to treat patients suffering from refractory epilepsy. These are epilepsies that cannot be treated by drugs, leaving 4,800,000 patients in a therapeutic impasse.

    Thanks to our patented technologies, we help healthcare professionals to better manage these patients suffering from severe epilepsies. 🏥

    NxNeuro medical devices enable more effective diagnosis and treatment, offering the chance of a cure to as many people as possible.

    Our goals: to treat more, to treat better, to treat without waiting, to give disease no chance. 🧠⚕️

    If you too would like to join us in the fight against epilepsy, don't wait any longer, contact us! 💬

    The future of neurotechs is Next ! 🚀

  • NxNeuro - Innovative neurosurgical technologies for epilespy

    Next Neurotech unveils the future of diagnosis and surgical treatment of drug-resistant epilepsy.

  • https://www.nxneuro.com/
Corporate interactions BETA
Corporate TypeTweets Articles
CCI Gard
CCI Gard
Chamber of commerce, Government Administration
CCI Gard
Chamber of commerce, Government Administration
Other

17 Oct 2024


French Tech Méditerranée
French Tech Méditerranée
French Tech, Software Development
French Tech Méditerranée
French Tech, Software Development
Other

14 Mar 2024


Créalia Occitanie
Créalia Occitanie
Civic and Social Organizations
Créalia Occitanie
Civic and Social Organizations
Other

10 Jan 2024


Caisse d’Epargne Caisse d’Epargne
Banking
Other

26 Feb 2024


Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

30 Jun 2024


Groupe Crédit Agricole Groupe Crédit Agricole
Bank, Banking
Other

19 Mar 2024


Similar entities
Loading...
Loading...
Social network dynamics